News
Press Release: Javelin Biotech Strengthens Board with Robin Robinson as Drug Discovery Shifts Towards Human-Based Models
Javelin Biotech appointed Dr. Robin Robinson to its board, reinforcing human-centric drug discovery aligned with the FDA Modernization Act 3.0.
NIH Announces Prioritization of Human-Based Research Technologies
New initiative aims to reduce use of animals in NIH-funded research.
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
FDA takes a significant step towards modernizing drug testing by phasing out animal requirements for monoclonal antibodies and other drugs.
Javelin Biotech Publication: Utilization of a Human Liver Tissue Chip for Drug-Metabolizing Enzyme Induction Studies of Perpetrator and Victim Drugs
A translational experimental system to predict clinical clearance values of both perpetrator and victim drugs
Javelin Biotech Publication: Pathway-Based Similarity Measurement to Quantify Transcriptomics Similarity Between Human Tissues and Preclinical Models
Development of a pathway-based similarity measurement to assess the human relevance of preclinical models
Javelin Biotech Publication: A Novel Milli-fluidic Liver Tissue Chip with Continuous Recirculation for Predictive Pharmacokinetics Applications
Joint publication with Pfizer in the AAPS journal